Invite: Seminar SELEQT-HF
Can intervention with Q10 and selenium slow down the ageing process, prevent cardiovascular disease and improve quality of life? An investigator meeting will be organised for SELEQT-HF in collaboration with Pharma Nord on Tuesday evening 4 February 2025 from 17:00. SELEQT-HF is the first registration-based randomised controlled trial within the Heart4Data consortium of the DCVA. […]
Heart4Data: Update SELEQT-HF and EPD-based registration Heart failure
Thursday, April 7, an update was given on the progress of RB-RCT research on Heart4Data’s infrastructure. Interest in this webinar was evidenced by the high attendance and responses. The following speakers and topics were covered: SELEQT-HF Setting up a heart failure care pathway This webinar was recorded and can be viewed on request. Would you […]
Heart4Data: Consortium agreement SELEQT-HF
A big milestone for Heart4Data: On June 1, 2023, the consortium agreement for the SELEQT-HF research project was signed! This project is a collaboration between ZonMw, Netherlands Heart Institute, NHR, Dutch CardioVascular Alliance, WCN, Harteraad, NVVC, Health-RI, NVT, Pharma Nord, Zuyderland, Erasmus MC, UMCG & Amsterdam UMC. Principal investigators Jeroen Schaap and Peter van der […]